WHO selects Roche, Primerdesign coronavirus tests for emergency use

By LabPulse.com staff writers

April 9, 2020 -- Molecular tests by Primerdesign and Roche are the first two to get emergency use listing by the World Health Organization (WHO) for SARS-CoV-2, paving the way for supply by the United Nations and other procurement agencies.

Primerdesign's genesig real-time polymerase chain reaction (PCR) for COVID-19 is an open system for laboratories with moderate sample testing capacity. Roche's cobas SARS-CoV-2 qualitative assay for use on the cobas 6800/8800 systems is a closed system assay for larger laboratories.

The WHO's emergency use listing pathway is designed to help procurement agencies and countries bring devices to market faster and expedite the availability of diagnostic tests in public health emergency situations, such as the COVID-19 pandemic. As of April 8, more than 1.3 million cases and more than 79,000 deaths have been reported globally, according to the organization.

Molecular testing and COVID-19: Where are we now?
As the COVID-19 pandemic accelerates, attention has been focused on how to effectively scale up the diagnostic testing that is needed to correctly manage...
Clinical diagnostics and the artificial intelligence boom
Artificial intelligence (AI) is becoming increasingly common in our everyday lives, but the role of AI in clinical diagnostics is the subject of intense...
Coronavirus relief bill omits payment for many lab-developed tests
The new coronavirus relief bill just passed by the U.S. House of Representatives has drawn fire from the American Association for Clinical Chemistry and...
FDA gives states, vendors more power in coronavirus fight
In a move it called an "unprecedented policy," the U.S. Food and Drug Administration (FDA) on March 16 once again relaxed its regulations on diagnostics...
FDA moves to improve coronavirus testing access
The U.S. Food and Drug Administration (FDA) has taken two actions in an effort to improve access to coronavirus testing.

Copyright © 2020 LabPulse.com

Last Updated np 4/8/2020 4:27:20 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email